The impact of symptoms on health-related quality of life in elderly pre-dialysis patients : effect and importance in the EQUAL study
(2019) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 34(10). p.1707-1715- Abstract
BACKGROUND: Quality of life (QoL) is an important outcome in chronic kidney disease (CKD). Patients feel that symptoms are an important determinant of QoL. However, this relation is unknown. The aims of this study were to investigate the impact of the number and severity of symptoms on QoL in elderly pre-dialysis patients, assessed by both the effect of symptoms and their importance relative to kidney function, and other clinical variables on QoL. METHODS: The European Quality study (EQUAL study) is an ongoing European prospective follow-up study in late Stage 4/5 CKD patients aged ≥65 years. We used patients included between March 2012 and December 2015. Patients scored their symptoms with the Dialysis Symptom Index, and QoL with the... (More)
BACKGROUND: Quality of life (QoL) is an important outcome in chronic kidney disease (CKD). Patients feel that symptoms are an important determinant of QoL. However, this relation is unknown. The aims of this study were to investigate the impact of the number and severity of symptoms on QoL in elderly pre-dialysis patients, assessed by both the effect of symptoms and their importance relative to kidney function, and other clinical variables on QoL. METHODS: The European Quality study (EQUAL study) is an ongoing European prospective follow-up study in late Stage 4/5 CKD patients aged ≥65 years. We used patients included between March 2012 and December 2015. Patients scored their symptoms with the Dialysis Symptom Index, and QoL with the research and development-36 (RAND-36) item Health Survey (RAND-36). The RAND-36 results in a physical component summary (PCS) and a mental component summary (MCS). We used linear regression to estimate the relation between symptoms and QoL at baseline and after 6 months, and to calculate the variance in QoL explained by symptoms. RESULTS: The baseline questionnaire was filled in by 1079 (73%) patients (median age 75 years, 66% male, 98% Caucasian), and the follow up questionnaire by 627 (42%) patients. At baseline, every additional symptom changed MCS with -0.81 [95% confidence interval (CI): -0.91 to -0.71] and PCS with -0.50 (95% CI: -0.62 to -0.39). In univariable analyses, number of symptoms explained 22% of MCS variance and 11% of PCS variance, whereas estimated glomerular filtration rate only explained 1%. CONCLUSIONS: In elderly CKD Stage 4/5 patients, symptoms have a substantial impact on QoL. This indicates symptoms should have a more prominent role in clinical decision-making.
(Less)
- author
- publishing date
- 2019
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- CKD, clinical epidemiology, pre-dialysis, quality of life, symptoms
- in
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- volume
- 34
- issue
- 10
- pages
- 9 pages
- publisher
- Oxford University Press
- external identifiers
-
- pmid:29939304
- scopus:85072888157
- ISSN
- 1460-2385
- DOI
- 10.1093/ndt/gfy167
- language
- English
- LU publication?
- no
- id
- a9bda947-4b01-45b3-8b10-16571fdc1670
- date added to LUP
- 2019-10-16 14:34:29
- date last changed
- 2023-12-04 02:18:03
@article{a9bda947-4b01-45b3-8b10-16571fdc1670,
abstract = {{<p>BACKGROUND: Quality of life (QoL) is an important outcome in chronic kidney disease (CKD). Patients feel that symptoms are an important determinant of QoL. However, this relation is unknown. The aims of this study were to investigate the impact of the number and severity of symptoms on QoL in elderly pre-dialysis patients, assessed by both the effect of symptoms and their importance relative to kidney function, and other clinical variables on QoL. METHODS: The European Quality study (EQUAL study) is an ongoing European prospective follow-up study in late Stage 4/5 CKD patients aged ≥65 years. We used patients included between March 2012 and December 2015. Patients scored their symptoms with the Dialysis Symptom Index, and QoL with the research and development-36 (RAND-36) item Health Survey (RAND-36). The RAND-36 results in a physical component summary (PCS) and a mental component summary (MCS). We used linear regression to estimate the relation between symptoms and QoL at baseline and after 6 months, and to calculate the variance in QoL explained by symptoms. RESULTS: The baseline questionnaire was filled in by 1079 (73%) patients (median age 75 years, 66% male, 98% Caucasian), and the follow up questionnaire by 627 (42%) patients. At baseline, every additional symptom changed MCS with -0.81 [95% confidence interval (CI): -0.91 to -0.71] and PCS with -0.50 (95% CI: -0.62 to -0.39). In univariable analyses, number of symptoms explained 22% of MCS variance and 11% of PCS variance, whereas estimated glomerular filtration rate only explained 1%. CONCLUSIONS: In elderly CKD Stage 4/5 patients, symptoms have a substantial impact on QoL. This indicates symptoms should have a more prominent role in clinical decision-making.</p>}},
author = {{Voskamp, Pauline W.M. and van Diepen, Merel and Evans, Marie and Caskey, Fergus J. and Torino, Claudia and Postorino, Maurizio and Szymczak, Maciej and Klinger, Marian and Wallquist, Carin and van de Luijtgaarden, Moniek W.M. and Chesnaye, Nicolas C. and Wanner, Christoph and Jager, Kitty J. and Dekker, Friedo W.}},
issn = {{1460-2385}},
keywords = {{CKD; clinical epidemiology; pre-dialysis; quality of life; symptoms}},
language = {{eng}},
number = {{10}},
pages = {{1707--1715}},
publisher = {{Oxford University Press}},
series = {{Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association}},
title = {{The impact of symptoms on health-related quality of life in elderly pre-dialysis patients : effect and importance in the EQUAL study}},
url = {{http://dx.doi.org/10.1093/ndt/gfy167}},
doi = {{10.1093/ndt/gfy167}},
volume = {{34}},
year = {{2019}},
}